Black Rock Inc. Fibrogen Inc Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
1 transactions
Others Institutions Holding FGEN
# of Institutions
10Shares Held
4MCall Options Held
35KPut Options Held
0-
Pictet Asset Management Sa Geneva 73, V81.37MShares$16.3 Million0.0% of portfolio
-
Intercontinental Wealth Advisors, LLC95.7KShares$1.13 Million0.06% of portfolio
-
Eaton Vance Management Boston, MA94.5KShares$1.12 Million0.0% of portfolio
-
Connective Capital Management, LLC Palo Alto, CA15KShares$177,6000.07% of portfolio
-
Cibc Private Wealth Group, LLC7.18KShares$84,9630.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $1.11B
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...